全文获取类型
收费全文 | 771篇 |
免费 | 33篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 31篇 |
妇产科学 | 12篇 |
基础医学 | 78篇 |
口腔科学 | 11篇 |
临床医学 | 57篇 |
内科学 | 123篇 |
皮肤病学 | 262篇 |
神经病学 | 30篇 |
特种医学 | 80篇 |
外科学 | 51篇 |
综合类 | 17篇 |
预防医学 | 24篇 |
眼科学 | 8篇 |
药学 | 22篇 |
中国医学 | 1篇 |
肿瘤学 | 15篇 |
出版年
2022年 | 5篇 |
2021年 | 4篇 |
2020年 | 4篇 |
2019年 | 14篇 |
2018年 | 26篇 |
2017年 | 11篇 |
2016年 | 5篇 |
2015年 | 10篇 |
2014年 | 29篇 |
2013年 | 29篇 |
2012年 | 27篇 |
2011年 | 41篇 |
2010年 | 29篇 |
2009年 | 38篇 |
2008年 | 35篇 |
2007年 | 41篇 |
2006年 | 22篇 |
2005年 | 25篇 |
2004年 | 29篇 |
2003年 | 23篇 |
2002年 | 17篇 |
2001年 | 31篇 |
2000年 | 31篇 |
1999年 | 19篇 |
1998年 | 17篇 |
1997年 | 15篇 |
1996年 | 22篇 |
1995年 | 9篇 |
1994年 | 20篇 |
1993年 | 12篇 |
1992年 | 8篇 |
1991年 | 4篇 |
1990年 | 10篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 23篇 |
1986年 | 22篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1977年 | 8篇 |
1976年 | 2篇 |
1975年 | 4篇 |
1973年 | 2篇 |
1967年 | 2篇 |
1966年 | 3篇 |
排序方式: 共有824条查询结果,搜索用时 15 毫秒
1.
C. Jacquet F. Goehringer E. Baux J.A. Conrad M.O. Ganne Devonec J.L. Schmutz G. Mathey H. Tronel T. Moulinet I. Chary-Valckenaere T. May C. Rabaud 《Médecine et maladies infectieuses》2019,49(2):112-120
Objective
The teaching hospital of Nancy, France, implemented a specific multidisciplinary care pathway (French acronym AMDPL) to improve the management of patients presenting with Lyme borreliosis (LB) suspicion. We aimed to assess the first year of activity of this care pathway.Patients and methods
We included all patients managed in the AMDPL pathway from November 1, 2016 to October 31, 2017. The first step was a dedicated Lyme disease consultation with an infectious disease specialist. Following this consultation, the LB diagnosis was either confirmed and adequate treatment was prescribed, or a differential diagnosis was established and patients received adequate management, or further investigations were required and patients were offered multidisciplinary management as part of a day hospitalization.Results
A total of 468 patients were included. LB diagnosis was confirmed in 15% of patients (69/468), 49% of patients received a differential diagnosis, and 26% (122/468) of patients had the LB diagnosis ruled out without receiving any other diagnosis.Conclusions
This is to our knowledge the first multidisciplinary center implemented in France for the management of patients presenting with LB suspicion related to polymorphous signs and symptoms. Several diagnoses could be confirmed or corrected, although some symptoms and complaints could not be explained. This cohort could improve our knowledge of LB and its differential diagnoses. 相似文献2.
3.
4.
During seven years, 212 small bowel examinations are made on patients with suspected small bowel obstruction by barium infusion. We find all the main small bowel pathology: Crohn's disease (16.5%), carcinomatosis (14.6%), neoplasia (10.3%), vascular disease (17.8%), actinic enteritis (9.5%) and miscellanous (18%). The small bowel infusion is normal in 15%. Surgery is avoided in 51% of the cases. There is non complications associated with the examination but in 12% of the cases, the examination is unsuccessful. 相似文献
5.
6.
M. Schmutz K. Klebs V. Baltzer 《Journal of neural transmission (Vienna, Austria : 1996)》1988,72(3):245-257
Summary The influence of antiepileptics on the evolution of rat amygdaloid kindling was studied.Under placebo conditions clonic convulsions and a spike-wave EEG pattern developed. Diazepam, clonazepam, clobazam and phenobarbital were most effective in suppressing the evolution of kindling; the effects of valproate sodium, ethosuximide and acetazolamide were somewhat less pronounced in this respect. Carbamazepine, oxcarbazepine and phenytoin, on the other hand, enhanced kindling development, i.e. the increase in duration of after-discharge was faster than in the placebo group. The results indicate that under the above experimental conditions drugs with no anti-absence component can be distinguished from those with an anti-absence component. The mechanism of action underlying the observed effects is not yet known; the hypothesis that under special conditions protective inhibitory neuronal activity can develop to absence type seizures is proposed. 相似文献
7.
CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity 总被引:8,自引:3,他引:5
下载免费PDF全文
![点击此处可从《British journal of pharmacology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
G E Fagg H R Olpe M F Pozza J Baud M Steinmann M Schmutz C Portet P Baumann K Thedinga H Bittiger 《British journal of pharmacology》1990,99(4):791-797
1. The pharmacological properties of CGP 37849 (DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid; 4-methyl-APPA) and its carboxyethylester, CGP 39551, novel unsaturated analogues of the N-methyl-D-aspartate (NMDA) receptor antagonist, 2-amino-5-phosphonopentanoate (AP5), were evaluated in rodent brain in vitro and in vivo. 2. Radioligand binding experiments demonstrated that CGP 37849 potently (Ki 220 nM) and competitively inhibited NMDA-sensitive L-[3H]-glutamate binding to postsynaptic density (PSD) fractions from rat brain. It inhibited the binding of the selective NMDA receptor antagonist, [3H]-((+/-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonate (CPP), with a Ki of 35 nM, and was 4, 5 and 7 fold more potent than the antagonists [+/-)-cis-4-phosphonomethylpiperidine-2-carboxylic acid) (CGS 19755), CPP and D-AP5, respectively. Inhibitory activity was associated exclusively with the trans configuration of the APPA molecule and with the D-stereoisomer. CGP 39551 showed weaker activity at NMDA receptor recognition sites and both compounds were weak or inactive at 18 other receptor binding sites. 3. CGP 37849 and CGP 39551 were inactive as inhibitors of L-[3H]-glutamate uptake into rat brain synaptosomes and had no effect on the release of endogenous glutamate from rat hippocampal slices evoked by electrical field stimulation. 4. In the hippocampal slice in vitro, CGP 37849 selectively and reversibly antagonized NMDA-evoked increases in CA1 pyramidal cell firing rate.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
8.
Promoting clinically effective practice: general practitioners' awareness of sources of research evidence 总被引:3,自引:1,他引:2
Prescott K; Lloyd M; Douglas HR; Haines A; Humphrey C; Rosenthal J; Watt I 《Family practice》1997,14(4):320-323
BACKGROUND: Practitioners are being encouraged to base their clinical
practice on research evidence. In order to do this, they must be aware of
and use the sources of evidence. METHODS: A questionnaire survey was
undertaken to establish GPs' awareness of research evidence in their
clinical practice and, in fundholding practices, its influence on
purchasing plans. Questionnaires were sent to 360 lead fundholders in North
Thames Region and 440 of a random sample of the remaining general
practitioners in the region for comparison. RESULTS: Questionnaires were
returned by 62% of lead fundholders and 63% of GPs in the random sample.
There was limited use of the electronic sources of clinical effectiveness.
There was greater reported awareness of published sources of research
evidence and fundholding GPs were significantly more likely to have
referred to publications summarizing research evidence. CONCLUSIONS: GPs
seem to make more use of published clinical effectiveness sources than the
electronic databases. Consequently, they need educational and technical
support if they are to make full use of the available sources of research
evidence available in other media.
相似文献
9.
10.
Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Clinical and experimental immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
H. L
HR U. TREICHEL T. PORALLA M. MANNS K. H. MEYER ZUM BÜSCHENFELDE B. FLEISCHER 《Clinical and experimental immunology》1992,88(1):45-49
Autoantibodies against the human asialoglycoprotein receptor (ASGPR) occur in the sera of patients with autoimmune liver disorders. Liver-infiltrating T cell clones that specifically recognize the ASGPR have been described in patients with autoimmune chronic active hepatitis (AI-CAH) and primary biliary cirrhosis (PBC). Recently, we have shown that peripheral blood mononuclear cells (PBMC) from patients with AI-CAH or PBC but not chronic viral hepatitis secreted anti-ASGPR antibodies in vitro. In this study we characterized the influence of liver-infiltrating T cells on the secretion of ASGPR-specific autoantibodies by autologous B cells in cell culture supernatants. T cell clones from liver biopsies of three patients with chronic autoimmune liver disorders (one with AI-CAH, two with PBC) were isolated and investigated for their proliferative response to soluble ASGPR and their helper function provided to autoantibody-secreting B lymphocytes. PBMC from these patients secreted autoantibodies spontaneously in their cell culture supernatants and showed a proliferative response to ASGPR. T cell-depleted PBMC, however, lacked spontaneous antibody secretion. Four CD4+CD8- liver-infiltrating T cell clones showed a proliferative response to ASGPR and also induced spontaneous anti-ASGPR antibody production in cell culture supernatants when added to autologous T cell depleted PBMC. Activated supernatants of these T cell clones failed to induce antibody production. None of seven CD4+CD8- and two CD4-CD8+ T cell clones non-responding to ASGPR provided this help for antibody secretion. Anti-ASGPR secretion in vitro could not be inhibited by the addition of MoAbs raised against monomorphic determinants on HLA class II molecules. The addition of purified ASGPR or polyclonal-activating pokeweed mitogen showed no influence on the production of autoantibodies in these cultures. These data show that B lymphocytes require T cell help for the production of ASGPR-specific antibodies. This help can be provided by ASGPR-responsive T helper cells via cellular interactions. 相似文献